EFFECT OF CYCLOOXYGENASE-1 POLYMORPHISMS ON URINARY 11-DEHYDROTHROMBOXANE B2 LEVELS IN PATIENTS UNDERGOING STENT IMPLANTATION PRETREATED WITH ASPIRIN

G. Latkovskis; N. Licis; B. Krivmane; E. Liepins; M. Dambrova; I. Urtane; A. Knipse; M. Zabunova; M. Berzina; A. Erglis

EFFECT OF CYCLOOXYGENASE-1 POLYMORPHISMS ON URINARY 11-DEHYDROTHROMBOXANE B2 LEVELS IN PATIENTS UNDERGOING STENT IMPLANTATION PRETREATED WITH ASPIRIN

G. Latkovskis, N. Licis, B. Krivmane, E. Liepins, M. Dambrova, I. Urtane, A. Knipse, M. Zabunova, M. Berzina, A. Erglis

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	520
Pages (from-to)	110-111
Journal	Atherosclerosis Supplements
Volume	12
Issue number	1
Publication status	Published - Jun 2011
Event	79th Congress of the European Atherosclerosis Society (EAS) - Gothenburg, Sweden Duration: 26 Jun 2011 → 29 Jun 2011 Conference number: 79 https://www.medscape.com/viewcollection/32070

Field of Science*

3.1 Basic medicine
3.2 Clinical medicine

Publication Type*

3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Access to Document

https://www.sciencedirect.com/science/article/abs/pii/S1567568811705219

Cite this

Latkovskis, G., Licis, N., Krivmane, B., Liepins, E., Dambrova, M., Urtane, I., Knipse, A., Zabunova, M., Berzina, M., & Erglis, A. (2011). EFFECT OF CYCLOOXYGENASE-1 POLYMORPHISMS ON URINARY 11-DEHYDROTHROMBOXANE B2 LEVELS IN PATIENTS UNDERGOING STENT IMPLANTATION PRETREATED WITH ASPIRIN. Atherosclerosis Supplements, 12(1), 110-111. Article 520. https://www.sciencedirect.com/science/article/abs/pii/S1567568811705219

@article{1a450203f17740858a64d9de239aad6c,

title = "EFFECT OF CYCLOOXYGENASE-1 POLYMORPHISMS ON URINARY 11-DEHYDROTHROMBOXANE B2 LEVELS IN PATIENTS UNDERGOING STENT IMPLANTATION PRETREATED WITH ASPIRIN",

author = "G. Latkovskis and N. Licis and B. Krivmane and E. Liepins and M. Dambrova and I. Urtane and A. Knipse and M. Zabunova and M. Berzina and A. Erglis",

year = "2011",

month = jun,

language = "English",

volume = "12",

pages = "110--111",

journal = "Atherosclerosis Supplements",

issn = "1567-5688",

publisher = "Elsevier Ireland Ltd",

number = "1",

note = "79th Congress of the European Atherosclerosis Society (EAS), EAS 2011 ; Conference date: 26-06-2011 Through 29-06-2011",

url = "https://www.medscape.com/viewcollection/32070",

}

Latkovskis, G, Licis, N, Krivmane, B, Liepins, E , Dambrova, M , Urtane, I, Knipse, A, Zabunova, M, Berzina, M & Erglis, A 2011, 'EFFECT OF CYCLOOXYGENASE-1 POLYMORPHISMS ON URINARY 11-DEHYDROTHROMBOXANE B2 LEVELS IN PATIENTS UNDERGOING STENT IMPLANTATION PRETREATED WITH ASPIRIN', Atherosclerosis Supplements, vol. 12, no. 1, 520, pp. 110-111. <https://www.sciencedirect.com/science/article/abs/pii/S1567568811705219>

TY - JOUR

T1 - EFFECT OF CYCLOOXYGENASE-1 POLYMORPHISMS ON URINARY 11-DEHYDROTHROMBOXANE B2 LEVELS IN PATIENTS UNDERGOING STENT IMPLANTATION PRETREATED WITH ASPIRIN

AU - Latkovskis, G.

AU - Licis, N.

AU - Krivmane, B.

AU - Liepins, E.

AU - Dambrova, M.

AU - Urtane, I.

AU - Knipse, A.

AU - Zabunova, M.

AU - Berzina, M.

AU - Erglis, A.

N1 - Conference code: 79

PY - 2011/6

Y1 - 2011/6

UR - https://www-webofscience-com.db.rsu.lv/wos/alldb/full-record/WOS:000300159000516

M3 - Meeting Abstract

SN - 1567-5688

VL - 12

SP - 110

EP - 111

JO - Atherosclerosis Supplements

JF - Atherosclerosis Supplements

IS - 1

M1 - 520

T2 - 79th Congress of the European Atherosclerosis Society (EAS)

Y2 - 26 June 2011 through 29 June 2011

ER -

EFFECT OF CYCLOOXYGENASE-1 POLYMORPHISMS ON URINARY 11-DEHYDROTHROMBOXANE B2 LEVELS IN PATIENTS UNDERGOING STENT IMPLANTATION PRETREATED WITH ASPIRIN

Field of Science*

Publication Type*

Access to Document

Other files and links

Cite this